GHW International (SEHK:9933) Stock Flat As Profit Jumps Meet 37x P/E

GHW International’s stock closed at HK$1.60 on Wednesday, flat over the past month even after a headline grabbing earnings jump. The market reaction has been muted while the chemicals group posted basic earnings per share of ¥0.031 for the first half of 2026 and trailing earnings growth of 128.6% over the past year.

The catch is valuation. GHW International now trades on a P/E of 37x, compared with an industry level of 9.9x, even as net profit margin sits at 0.8%. That gap between improved profits and a rich multiple is the core story behind this latest result.

Love the sharp earnings jump at GHW International but concerned about paying 37x earnings for a stock with a 0.8% net margin? Check out the list of solid balance sheet and fundamentals stocks (423 results) for companies that combine stronger profitability with more grounded valuations.

H1 2026 Earnings Summary

• Revenue (H1 2026 vs H1 2025): ¥2,232.802m vs. ¥1,856.712m (reported growth of 20.3%)
• Net Income (Excl. Extra Items, H1 2026 vs H1 2025): ¥29.389m vs. ¥7.036m (very large year on year increase)
• Basic EPS (H1 2026 vs H1 2025): ¥0.031 vs. ¥0.00745 (very large year on year increase)
• Net Profit Margin (Trailing 12 Months vs Prior Year): 0.8% vs. 0.4% (margin has doubled year on year)

Prefer clean charts over another wall of earnings figures and valuation ratios? View GHW International’s complete financial picture, including a clear look at its valuation, in our company report for GHW International.

GHW International: Earnings Momentum Supports Cautious Optimism

For investors leaning positive on GHW International, the latest half year numbers give some support. Revenue of ¥2,232.802m compared with ¥1,856.712m a year earlier points to a healthier top line across its diversified chemicals and healthcare mix. Net income excluding extra items grew from ¥7.036m to ¥29.389m and basic EPS moved from ¥0.00745 to ¥0.031. The trailing net margin of 0.8% compared with 0.4% a year earlier suggests the group is converting slightly more of that broader revenue base into profit.

GHW International: Thin Margins Keep Risk Debate Alive

For the more cautious view on GHW International, the earnings picture still leaves room for concern. Net profit margin at 0.8%, even after improvement from 0.4%, remains very thin for a specialty chemicals and healthcare linked group. That leaves little room for error if pricing or costs move against the business. Recent share price performance also looks subdued, with the stock flat over 30 days and lower over 7 and 90 days, which suggests the market has not treated the latest profit lift as a clear turning point.

Thin margins and subdued share price moves can hint at deeper structural pressure points at GHW International. Review our independent risk analysis for GHW International which shows 2 important warning signs to see whether these issues are isolated or part of a broader risk pattern.

Stay Ahead With Simply Wall St

If the mix of strong recent EPS figures and a 37x P/E at GHW International has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a more attractive entry point. Once you own any stock, streamline your decisions with the Portfolio Command Center that focuses on key developments and filters out day to day noise. For a longer term view, tap into shared research and sentiment through the Community and see how other investors are thinking about opportunities like GHW International. This combined toolkit helps you spot both potential catalysts and emerging risks early so you can stay ahead of the market.

Seeking Alternatives Beyond GHW International?

Fresh stock ideas can start moving quickly once momentum builds. Use these focused lists to spot potential breakouts under the radar for now.

• Chase steady income streams by reviewing carefully filtered companies in the 408 dividend fortresses before yields get caught dropping as prices move.
• Zero in on resilient balance sheets through a curated 293 resilient stocks with low risk scores and stay ahead while these quieter compounders remain under the radar for now.
• Fuel your curiosity about the AI build out by scanning hand picked infrastructure players in the 55 AI infrastructure stocks while valuations still look grounded.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com